146 related articles for article (PubMed ID: 1334050)
1. Effects of niflumic acid on polyphosphoinositide and oxidative metabolism in polymorphonuclear leukocytes from healthy and thermally injured rats.
Tissot M; Roch-Arveiller M; Fontagne J; Giroud JP
Inflammation; 1992 Dec; 16(6):645-57. PubMed ID: 1334050
[TBL] [Abstract][Full Text] [Related]
2. Polyphosphoinositide metabolism in polymorphonuclear cells from healthy and thermally injured rats: effect of the immunomodulator RU 41740.
Tissot M; Mathieu J; Mirossay L; Thuret A; Giroud JP
J Leukoc Biol; 1991 Dec; 50(6):607-14. PubMed ID: 1658175
[TBL] [Abstract][Full Text] [Related]
3. Modulation of polymorphonuclear leukocyte responsiveness by copper (II)2 (niflumate)4.
Roch-Arveiller M; Maman L; Huy DP; Fontagne J; Giroud JP; Sorenson JR
Inflamm Res; 1995 May; 44(5):198-203. PubMed ID: 7655993
[TBL] [Abstract][Full Text] [Related]
4. Effect of an immunomodulating agent, RU 414740, on polymorphonuclear responsiveness after burn injury.
Roch-Arveiller M; Fontagne J; el Abbouyi A; Raichvarg D; Giroud JP
Inflammation; 1991 Dec; 15(6):437-45. PubMed ID: 1661708
[TBL] [Abstract][Full Text] [Related]
5. Aroclor 1242 stimulates the production of inositol phosphates in polymorphonuclear neutrophils.
Tithof PK; Contreras ML; Ganey PE
Toxicol Appl Pharmacol; 1995 Mar; 131(1):136-43. PubMed ID: 7878669
[TBL] [Abstract][Full Text] [Related]
6. Effect of piracetam on polyphosphoinositide metabolism, cytosolic calcium release, and oxidative burst in human polymorphonuclear cells: interaction with fMLP-induced stimulation.
Tissot M; Sarfati G; Roch-Arveiller M; Giroud JP
Biochem Pharmacol; 1999 Jan; 57(2):163-70. PubMed ID: 9890564
[TBL] [Abstract][Full Text] [Related]
7. Chemiluminescence of human and canine polymorphonuclear leukocytes in the absence of phagocytosis.
Harvath L; Amirault HJ; Andersen BR
J Clin Invest; 1978 May; 61(5):1145-54. PubMed ID: 207727
[TBL] [Abstract][Full Text] [Related]
8. Effects of tripeptides derived from milk proteins on polymorphonuclear oxidative and phosphoinositide metabolisms.
Migliore-Samour D; Roch-Arveiller M; Tissot M; Jazziri M; Keddad K; Giroud JP; Jollès P
Biochem Pharmacol; 1992 Aug; 44(4):673-80. PubMed ID: 1324681
[TBL] [Abstract][Full Text] [Related]
9. Anion channels, including ClC-3, are required for normal neutrophil oxidative function, phagocytosis, and transendothelial migration.
Moreland JG; Davis AP; Bailey G; Nauseef WM; Lamb FS
J Biol Chem; 2006 May; 281(18):12277-88. PubMed ID: 16522634
[TBL] [Abstract][Full Text] [Related]
10. Copper(II) complexes of a nonsteroidal anti-inflammatory drug niflumic acid. Synthesis, crystal structure of tetrakis-mu-(2-[3-(trifluoromethyl) phenyl]aminonicotinato)bis(dimethylsulfoxide)-dicopper(II) complex at 190 K. Anti-inflammatory properties.
Greenaway FT; Riviere E; Girerd JJ; Labouze X; Morgant G; Viossat B; Daran JC; Roch Arveiller M; Dung NH
J Inorg Biochem; 1999 Jul; 76(1):19-27. PubMed ID: 10530003
[TBL] [Abstract][Full Text] [Related]
11. Dopamine inhibition of superoxide anion production by polymorphonuclear leukocytes.
Yamazaki M; Matsuoka T; Yasui K; Komiyama A; Akabane T
J Allergy Clin Immunol; 1989 May; 83(5):967-72. PubMed ID: 2541191
[TBL] [Abstract][Full Text] [Related]
12. Restoration of postburn impaired lymphocyte responsiveness by nonsteroidal anti-inflammatory drugs is independent of prostaglandin E2 inhibition.
Mathieu J; Masson I; Chancerelle Y; Chanaud B; Strazlko S; De Sousa M; Kergonou JF; Giroud JP; Florentin I
J Leukoc Biol; 1994 Jan; 55(1):64-72. PubMed ID: 7506748
[TBL] [Abstract][Full Text] [Related]
13. [Effects of CN-100 on the functions of rat polymorphonuclear leukocytes].
Yoneta T; Kato H; Yoshida A; Ozeki M; Tagashira E
Nihon Yakurigaku Zasshi; 1991 Jan; 97(1):23-30. PubMed ID: 1646145
[TBL] [Abstract][Full Text] [Related]
14. The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine.
Gryglewski RJ; Szczeklik A; Wandzilak M
Biochem Pharmacol; 1987 Dec; 36(24):4209-13. PubMed ID: 2446631
[TBL] [Abstract][Full Text] [Related]
15. Prostacyclin and beraprost sodium as suppressors of activated rat polymorphonuclear leukocytes.
Kainoh M; Imai R; Umetsu T; Hattori M; Nishio S
Biochem Pharmacol; 1990 Feb; 39(3):477-84. PubMed ID: 2154985
[TBL] [Abstract][Full Text] [Related]
16. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
Kimura I; Kawasaki M; Matsuda A; Kataoka M; Kokurba Y
Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
[TBL] [Abstract][Full Text] [Related]
17. Circulating factors contribute to elevation of intracellular cyclic-3',5'-adenosine monophosphate and depression of superoxide anion production in polymorphonuclear leukocytes following thermal injury.
Bjornson AB; Somers SD; Knippenberg RW; Bjornson HS
J Leukoc Biol; 1992 Oct; 52(4):407-14. PubMed ID: 1328442
[TBL] [Abstract][Full Text] [Related]
18. Priming effect of hydroxyapatite on the chemiluminescence response in human polymorphonuclear leukocytes.
Nagase M; Nishiya H; Noda M
FEBS Lett; 1994 Jul; 349(1):13-6. PubMed ID: 8045289
[TBL] [Abstract][Full Text] [Related]
19. G protein activation and mediator release from human neutrophils and platelets after stimulation with sodium fluoride and receptor-mediated stimuli.
Brom C; Brom J; König W
Immunology; 1991 Jul; 73(3):287-92. PubMed ID: 1652553
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin enhances superoxide production by FMLP-stimulated polymorphonuclear leukocytes in hemodialysis patients.
Chen HC; Tsai JC; Tsai JH; Lai YH
Kidney Int; 1997 Nov; 52(5):1390-4. PubMed ID: 9350664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
